Psyence Biomedical Valuation
| PBMWW Stock | 0.01 0.0006 7.50% |
Psyence Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Psyence Biomedical from analyzing the company fundamentals such as return on asset of -1.26, and Beta of -0.42 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Psyence Biomedical's price fluctuation is out of control at this time. Calculation of the real value of Psyence Biomedical is based on 3 months time horizon. Increasing Psyence Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Psyence stock is determined by what a typical buyer is willing to pay for full or partial control of Psyence Biomedical Ltd. Since Psyence Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Psyence Stock. However, Psyence Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0074 | Real 0.007104 | Hype 0.006055 |
The intrinsic value of Psyence Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Psyence Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Psyence Biomedical Ltd helps investors to forecast how Psyence stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Psyence Biomedical more accurately as focusing exclusively on Psyence Biomedical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Psyence Biomedical's intrinsic value based on its ongoing forecasts of Psyence Biomedical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Psyence Biomedical's closest peers.
Psyence Biomedical Cash |
|
Psyence Valuation Trend
Analysing the historical paterns of Psyence Biomedical's enterprise value and its market capitalization is a good way to estimate and gauge the value of Psyence Biomedical Ltd over time and is usually enough for investors to make rational market timing decisions.
Psyence Valuation Data Drivers
Psyence Biomedical Total Value Analysis
Psyence Biomedical Ltd is at this time anticipated to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Psyence Biomedical fundamentals before making investing decisions based on enterprise value of the companyPsyence Biomedical Asset Utilization
One of the ways to look at asset utilization of Psyence is to check how much profit was generated for every dollar of assets it reports. Psyence Biomedical holds a negative application of assets of -1.26 pct., losing USD0.0126 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Psyence Biomedical Ltd shows how discouraging it operates for each dollar spent on its assets.About Psyence Biomedical Valuation
Our relative valuation model uses a comparative analysis of Psyence Biomedical. We calculate exposure to Psyence Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Psyence Biomedical's related companies.Psyence Biomedical Current Valuation Indicators
Valuation refers to the process of determining the present value of Psyence Biomedical Ltd and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Psyence we look at many different elements of the entity such as Psyence's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Psyence Biomedical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Psyence Biomedical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Psyence Biomedical's worth.Additional Tools for Psyence Stock Analysis
When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.